Jenster G - Search Results

1

Androgen receptor profiling predicts prostate cancer outcome.

Stelloo S, Nevedomskaya E, van der Poel HG, de Jong J, van Leenders GJ, Jenster G, Wessels LF, Bergman AM, Zwart W. Stelloo S, et al. Among authors: jenster g. EMBO Mol Med. 2015 Nov;7(11):1450-64. doi: 10.15252/emmm.201505424. EMBO Mol Med. 2015. PMID: 26412853 Free PMC article.

2

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens.

Veldscholte J, Ris-Stalpers C, Kuiper GG, Jenster G, Berrevoets C, Claassen E, van Rooij HC, Trapman J, Brinkmann AO, Mulder E. Veldscholte J, et al. Among authors: jenster g. Biochem Biophys Res Commun. 1990 Dec 14;173(2):534-40. doi: 10.1016/s0006-291x(05)80067-1. Biochem Biophys Res Commun. 1990. PMID: 2260966

3

Androgen receptor mutations.

Brinkmann AO, Jenster G, Ris-Stalpers C, van der Korput JA, Brüggenwirth HT, Boehmer AL, Trapman J. Brinkmann AO, et al. Among authors: jenster g. J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):443-8. doi: 10.1016/0960-0760(95)00090-m. J Steroid Biochem Mol Biol. 1995. PMID: 7626493 Free article. Review.

4

The role of the androgen receptor in the development and progression of prostate cancer.

Jenster G. Jenster G. Semin Oncol. 1999 Aug;26(4):407-21. Semin Oncol. 1999. PMID: 10482183 Review.

5

AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR.

Li P, Lee H, Guo S, Unterman TG, Jenster G, Bai W. Li P, et al. Among authors: jenster g. Mol Cell Biol. 2003 Jan;23(1):104-18. doi: 10.1128/MCB.23.1.104-118.2003. Mol Cell Biol. 2003. PMID: 12482965 Free PMC article.

6

Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment.

Marques RB, Erkens-Schulze S, de Ridder CM, Hermans KG, Waltering K, Visakorpi T, Trapman J, Romijn JC, van Weerden WM, Jenster G. Marques RB, et al. Among authors: jenster g. Int J Cancer. 2005 Nov 1;117(2):221-9. doi: 10.1002/ijc.21201. Int J Cancer. 2005. PMID: 15900601

7

The human PC346 xenograft and cell line panel: a model system for prostate cancer progression.

Marques RB, van Weerden WM, Erkens-Schulze S, de Ridder CM, Bangma CH, Trapman J, Jenster G. Marques RB, et al. Among authors: jenster g. Eur Urol. 2006 Feb;49(2):245-57. doi: 10.1016/j.eururo.2005.12.035. Epub 2006 Jan 6. Eur Urol. 2006. PMID: 16413664 Review.

8

Evolution of the androgen receptor pathway during progression of prostate cancer.

Hendriksen PJ, Dits NF, Kokame K, Veldhoven A, van Weerden WM, Bangma CH, Trapman J, Jenster G. Hendriksen PJ, et al. Among authors: jenster g. Cancer Res. 2006 May 15;66(10):5012-20. doi: 10.1158/0008-5472.CAN-05-3082. Cancer Res. 2006. PMID: 16707422 Free article.

9

Gene expression profiling of the human prostate zones.

van der Heul-Nieuwenhuijsen L, Hendriksen PJ, van der Kwast TH, Jenster G. van der Heul-Nieuwenhuijsen L, et al. Among authors: jenster g. BJU Int. 2006 Oct;98(4):886-97. doi: 10.1111/j.1464-410X.2006.06427.x. BJU Int. 2006. PMID: 16978289

10

TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.

Hermans KG, van Marion R, van Dekken H, Jenster G, van Weerden WM, Trapman J. Hermans KG, et al. Among authors: jenster g. Cancer Res. 2006 Nov 15;66(22):10658-63. doi: 10.1158/0008-5472.CAN-06-1871. Cancer Res. 2006. PMID: 17108102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters